🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Grateful to have the opportunity to present our work on the representation and reporting of minoritized racial and ethnic groups in clinical trials on immune checkpoint inhibitors at the 16th AACR Conference on the Science of Cancer Health Disparities in Orlando, FL. #AACRdisp23

Thankful for the chance to present two abstracts at the world’s largest breast cancer conference, the San Antonio Breast Cancer Symposium last December 5-9, 2023 in San Antonio, Texas. Thank you to our co-authors and collaborators! #SABCS23 #SABCS

Sharing our paper on the significance of ERBB2 (HER2)-low expression in #breastcancer in JAMA Network Open. Thanks to all co-authors, especially to Dr. Thaer Khoury and Dr. Song Yao, for allowing me to take part and present this work at #SABCS2023. jamanetwork.com/journals/jaman…

Sharing our paper on the epidemiology of the risk of early vs. late recurrence of women diagnosed with early stage ER+ #breastcancer from the prospective Pathways Study published in #JNCI. Thank you very much to all our co-authors and collaborators! academic.oup.com/jnci/article-a…

Thrilled to share our paper on the under-representation and under-reporting of racial and ethnic minorities in immune checkpoint inhibitor clinical trials recently published in JCO Oncology Practice. Thank you to all co-authors! Check out the full paper here: ascopubs.org/doi/10.1200/OP…

Thank you for featuring our work, Medscape! Minorities Remain Underrepresented in ICI Cancer Trials medscape.com/viewarticle/mi…